Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

For information on drugs that are off patent or close to expiry

— Research and development, Mexico

To get Information about patents for active substance and indications

— Speciality pharmaceuticals, Israel

To update my knowledge in several markets

— Marketing professional, Spain

To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs

— Retail pharmacist, USA

To find examples of compounds losing patent protection in 2016-2019

— Researcher, Poland

Generated: May 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050633

« Back to Dashboard
NDA 050633 describes CEFPIRAMIDE SODIUM, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the CEFPIRAMIDE SODIUM profile page.

The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.

Summary for NDA: 050633

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Jan 31, 1989TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Jan 31, 1989TE:RLD:No

Summary for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 10GM BASE/VIAL
Approval Date:Jan 31, 1989TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To find generic producers around the world for specific active ingredients.

— Pharmaceutical wholesaler, Estonia

To see which patents for drugs are expiring to do pipeline planning for our company

— Business development manager, South Africa

To know which brands are on and off patent

— Advertising sales pharma companies, USA

To explore which pharmaceutical products are still under patent protection

— Managing partner for pharmaceutical company, Lebanon

To see which oncology / CNS drug patents face expiration in Brazil

— Business development coordinator, pharmaceutical lab, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot